| Page 1930 | Kisaco Research
 

Mike Henry

Co-Founder & CEO
Mythic

Mike Henry

Co-Founder & CEO
Mythic

Mike Henry

Co-Founder & CEO
Mythic
 

Ian Buck

VP & GM
Tesla Data Center Business: NVIDIA

Ian Buck is vice president of NVIDIA's Accelerated Computing business unit, which includes all hardware and software product lines, third-party enablement, and marketing activities for GPU computing.

Buck joined NVIDIA in 2004 and created CUDA, which remains the established leading platform for accelerated-based parallel computing. Before joining NVIDIA, he was the development lead on Brook, which was the forerunner to generalized computing on GPUs.

Ian Buck

VP & GM
Tesla Data Center Business: NVIDIA

Ian Buck

VP & GM
Tesla Data Center Business: NVIDIA

Ian Buck is vice president of NVIDIA's Accelerated Computing business unit, which includes all hardware and software product lines, third-party enablement, and marketing activities for GPU computing.

Buck joined NVIDIA in 2004 and created CUDA, which remains the established leading platform for accelerated-based parallel computing. Before joining NVIDIA, he was the development lead on Brook, which was the forerunner to generalized computing on GPUs.

Buck holds a Ph.D. in computer science from Stanford University and Bachelor of Science in computer science from Princeton University.

STYR Labs video - Making Better Babies
 

Joy Chen

Board Chairman & CEO
H2O+ Beauty

Joy Chen

Board Chairman & CEO
H2O+ Beauty

Joy Chen

Board Chairman & CEO
H2O+ Beauty
Spotlight on...Matthew Wiseman, Alantra
 

Malcolm Faers

Science Fellow
Bayer Crop Science

Malcolm Faers

Science Fellow
Bayer Crop Science

Malcolm Faers

Science Fellow
Bayer Crop Science
 

Chris Urch

Head of Chemistry
Redag Crop Protection

I did my first degree at Cambridge reading natural sciences and chemistry.  I stayed at Cambridge to complete my PhD on organic synthesis with Professor Ian Fleming and then moved to the United States to undertake post-doctoral research, again on organic synthesis, with Professor Barry Trost.  On returning to this country I started work for ICI Agrochemicals where I remained for 16 years as it became Zeneca and eventually Syngenta.  During this time, I worked on both fungicide and insecticide research, principally sterol biosynthesis inhibitors and acetylcholine receptor agonists respective

Chris Urch

Head of Chemistry
Redag Crop Protection

Chris Urch

Head of Chemistry
Redag Crop Protection

I did my first degree at Cambridge reading natural sciences and chemistry.  I stayed at Cambridge to complete my PhD on organic synthesis with Professor Ian Fleming and then moved to the United States to undertake post-doctoral research, again on organic synthesis, with Professor Barry Trost.  On returning to this country I started work for ICI Agrochemicals where I remained for 16 years as it became Zeneca and eventually Syngenta.  During this time, I worked on both fungicide and insecticide research, principally sterol biosynthesis inhibitors and acetylcholine receptor agonists respectively.

 

After leaving Syngenta I joined Amura, a start-up company in Cambridge.  Amura was developing antibiotics and in particular a β-lactamase inhibitor.  I stayed with Amura for three years and then joined Glycoform for six years, a spin-out from the University of Oxford, where I was the Research Director.  Glycoform researched various ways of improving pharmaceuticals by the use of sugars.

 

After leaving Glycoform I worked as a consultant, increasingly for Redag Crop Protection who are researching novel agrochemicals.  Four years ago, I joined them full time as Head of Chemistry.

Biological Crop Protection - Global Market Overview